Stockholders' Equity - Additional Information (Details) - $ / shares	3 Months Ended		9 Months Ended
	Sep. 30, 2025	Sep. 30, 2024	Sep. 30, 2025	Sep. 30, 2024	Dec. 31, 2024
Stockholders Equity Note Disclosure [Line Items]
Common stock, shares authorized (in shares)	60,000,000		60,000,000		60,000,000
Common stock, par value (in dollars per share)	$ 0.01		$ 0.01		$ 0.01
Common stock, shares issued (in shares)	33,960,838		33,960,838		33,694,396
Common stock, shares outstanding (in shares)	33,960,838		33,960,838		33,694,396
Preferred stock, shares authorized (in shares)	5,000,000		5,000,000		5,000,000
Preferred stock, par value (in dollars per share)	$ 0.01		$ 0.01		$ 0.01
Preferred stock, shares outstanding (in shares)	0		0		0
Restricted Stock
Stockholders Equity Note Disclosure [Line Items]
Antidilutive stock excluded from earning per share (in shares)	0	733,000	0	409,000